Shilpa Medicare partners with Orion for Recombinant Human Albumin for European market
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
The company has posted net profit of Rs. 91.13 crores for the Financial Year ended March 31, 2025
Ideal for extreme dry skin and hyperkeratotic conditions such as psoriasis and ichthyosis, Ureaderm offers the next step in evidence-based, effective skin hydration
EBITDA before special items decreases to €4.08 billion (7.4%)
The company reported 30.1% jump in Q4 FY25 PAT at Rs. 1,222 crore
Over 1500 stakeholders representing food businesses, packaging industries, recycling associations, regulatory bodies, environmental organizations, consumer groups, farmer groups, government departments participated in the consultation
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
Padmanabhan brings over two decades of extensive experience in FMCG sector
Subscribe To Our Newsletter & Stay Updated